Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

Budget 2026-27: Government reduces customs duties on 17 medications to alleviate financial strain for cancer patients.

01 Feb, 2026

ANDA Litigation Resolutions - Q4 2025 | Robins Kaplan LLP - JDSupra

30 Jan, 2026

How the pharmaceutical industry is managing a $300 billion patent expiration challenge | PharmaVoice

30 Jan, 2026

Patent denial for multinational corporation's cancer medication; generics expected to launch in the market - The Economic Times

23 Jan, 2026

See More